Combination Therapy of PPAR Ligands and Inhibitors of Arachidonic Acid in Lung Cancer
Figure 1
Inflammatory products stimulate cPLA2α which increases levels of AA available
to be metabolized by the LOX/COX pathways. LOX/COX enzymes’ products,
leukotrienes and prostaglandins, induce cell proliferation. Natural ligands for
PPARγ are also produced by the LOX/COX
pathways. Activation of PPARγ balances the effect of leukotrienes and
prostaglandins inducing apoptosis through various mechanisms. However,
activation of PPARγ may also induce COX-2 and IL-8 expressions. Furthermore,
overexpression of PPARγ may decrease invasion and induce
differentiation from a mesenchymal
to an epithelial-like phenotype.